Short answer
CLOVER HEALTH INVESTMENTS, CORP. /DE (CLOV) filed an 8-K current report with the SEC on June 12, 2026 reporting Item 5.07 (Submission of Matters to a Vote of Security Holders). Three Class II directors elected through 2029: Demetrios Kouzoukas, Andrew Toy, and Thomas Tran.
CLOVER HEALTH INVESTMENTS, CORP. /DE 8-K event analysis
AI summary of each reported item and its exhibits
Item 5.07 · Submission of Matters to a Vote of Security Holders
- Three Class II directors elected through 2029: Demetrios Kouzoukas, Andrew Toy, and Thomas Tran
- Executive compensation for 2025 approved on an advisory basis, with 1,003,065,402 votes for
- Ernst & Young appointment ratified for fiscal 2026, with 1,188,467,663 votes for
- Class B holders’ 10-vote-per-share rights create substantial voting power versus Class A holders
Generated from the filing text and exhibits; verify against the original. What 8-K item codes mean
Other CLOVER HEALTH INVESTMENTS, CORP. /DE 8-K filings
Get the next CLOV 8-K as it lands
Follow CLOV for push alerts, or ask the research agent what this filing means.